PH25728A - Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type - Google Patents

Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Info

Publication number: PH25728A
Authority: PH; Philippines
Prior art keywords: antigestagen; trilostane; synthesis inhibitor; progesteron; combined use
Prior art date: 1987-06-16

Application number

PH37078A

Other languages

English (en)

Inventor

Walter Dr Elger

Sybille Dr Beir

Beate Kosub

Marrianne Fanrich

Of Dr Krzysztof Dr Chwalisz

Gordon Dr Oliver

Original Assignee

Schering

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-16

Filing date

1988-06-15

Publication date

1991-10-18

1988-06-15 Application filed by Schering filed Critical Schering

1991-10-18 Publication of PH25728A publication Critical patent/PH25728A/en

Links

RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 4
239000003418 antiprogestin Substances 0.000 title abstract 3
230000015572 biosynthetic process Effects 0.000 title abstract 2
CETKWEWBSMKADK-GSXVSZIWSA-N epostane Chemical compound C([C@]1(C)[C@@](C)(O)CC[C@H]1[C@@H]1CC2)C[C@@H]1[C@]1(C)[C@]32O[C@]3(C)C(O)=C(C#N)C1 CETKWEWBSMKADK-GSXVSZIWSA-N 0.000 title abstract 2
229950002674 epostane Drugs 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
KVJXBPDAXMEYOA-CXANFOAXSA-N trilostane Chemical compound OC1=C(C#N)C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@@]32O[C@@H]31 KVJXBPDAXMEYOA-CXANFOAXSA-N 0.000 title abstract 2
229960001670 trilostane Drugs 0.000 title abstract 2
206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
201000009273 Endometriosis Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
230000035935 pregnancy Effects 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PH37078A 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type PH25728A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873720420 DE3720420A1 (de)	1987-06-16	1987-06-16	Progesteronsynthesehemmer und antigestagene zur geburtseinleitung oder fuer den schwangerschaftsabbruch

Publications (1)

Publication Number	Publication Date
PH25728A true PH25728A (en)	1991-10-18

Family

ID=6329981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH37078A PH25728A (en)	1987-06-16	1988-06-15	Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Country Status (12)

Country	Link
EP (1)	EP0296097B1 (fr)
JP (1)	JP2716461B2 (fr)
AT (1)	ATE94391T1 (fr)
AU (1)	AU611160B2 (fr)
CA (1)	CA1318251C (fr)
DE (2)	DE3720420A1 (fr)
DK (1)	DK327288A (fr)
ES (1)	ES2059556T3 (fr)
IE (1)	IE63453B1 (fr)
IL (1)	IL86731A (fr)
PH (1)	PH25728A (fr)
ZA (1)	ZA884315B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3522753B2 (ja) *	1992-09-25	2004-04-26	バーンズ，クライブ	ビールラインにおける汚染物質の堆積防止
GB2345851B (en) *	2000-01-18	2004-05-26	Gavin Paul Vinson	A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4062954A (en) *	1976-12-27	1977-12-13	Sterling Drug Inc.	Process for using a steroid compound
IL68222A (en) *	1983-03-24	1987-02-27	Yeda Res & Dev	Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

1987
- 1987-06-16 DE DE19873720420 patent/DE3720420A1/de not_active Withdrawn
1988
- 1988-06-13 JP JP63143843A patent/JP2716461B2/ja not_active Expired - Fee Related
- 1988-06-14 DE DE88730135T patent/DE3884067D1/de not_active Expired - Fee Related
- 1988-06-14 ES ES88730135T patent/ES2059556T3/es not_active Expired - Lifetime
- 1988-06-14 AT AT88730135T patent/ATE94391T1/de not_active IP Right Cessation
- 1988-06-14 EP EP88730135A patent/EP0296097B1/fr not_active Expired - Lifetime
- 1988-06-14 IL IL86731A patent/IL86731A/xx not_active IP Right Cessation
- 1988-06-15 CA CA000569576A patent/CA1318251C/fr not_active Expired - Fee Related
- 1988-06-15 IE IE180488A patent/IE63453B1/en not_active IP Right Cessation
- 1988-06-15 PH PH37078A patent/PH25728A/en unknown
- 1988-06-15 DK DK327288A patent/DK327288A/da not_active Application Discontinuation
- 1988-06-16 AU AU17750/88A patent/AU611160B2/en not_active Ceased
- 1988-06-16 ZA ZA884315A patent/ZA884315B/xx unknown

Also Published As

Publication number	Publication date
AU611160B2 (en)	1991-06-06
DK327288D0 (da)	1988-06-15
IL86731A (en)	1992-11-15
DE3884067D1 (de)	1993-10-21
DE3720420A1 (de)	1988-12-29
DK327288A (da)	1988-12-17
CA1318251C (fr)	1993-05-25
EP0296097B1 (fr)	1993-09-15
ES2059556T3 (es)	1994-11-16
IL86731A0 (en)	1988-11-30
ATE94391T1 (de)	1993-10-15
EP0296097A3 (en)	1990-04-04
JPS63316725A (ja)	1988-12-26
IE63453B1 (en)	1995-04-19
ZA884315B (en)	1989-06-28
IE881804L (en)	1988-12-16
AU1775088A (en)	1988-12-22
EP0296097A2 (fr)	1988-12-21
JP2716461B2 (ja)	1998-02-18

Similar Documents

Publication	Publication Date	Title
GB2102287B (en)	1985-02-27	Use of aromatase-inhibitors with antiandrogens for treatment of prostatic hyperplasia.
EP0236684A3 (en)	1988-12-14	Galanthamine or analogues thereof for treating alzheimer's disease
DK37388D0 (da)	1988-01-26	Steroid-5-alfa-reduktaseinhibitorer
NZ256681A (en)	1997-10-24	Tablet containing ranitidine (or its salt), chewable base, and flavouring; the tablet is free of alginic acid with sodium bicarbonate
JPS5413651A (en)	1979-02-01	House ventilating device
PH25728A (en)	1991-10-18	Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type
ZA857721B (en)	1986-09-24	Process for treatment of rheumatic diseases
JPS5431952A (en)	1979-03-09	Temperature controller
NO883743D0 (no)	1988-08-22	Framgangsmaate og anordning for aa gi personlig luftbehandling ("air-condition").
JPS51113435A (en)	1976-10-06	Offering processor
JPS51141279A (en)	1976-12-04	Method of improving physical constitution of cattle
EP0151385A3 (en)	1985-12-27	Use of phytosterolglycosides for the treatment of elevated 5(6) alpha-epoxycholesterol levels
ES451701A1 (es)	1978-01-01	Procedimiento para la obtencion de y-lactonas de acidos 6 beta, 17-dihidroxi-7 alfa-(alcoxi inferior) -carbonil-3-oxo-17 alfa'pregn-4-eno-21-carboxilicos.
IE810158L (en)	1981-08-07	Control of ovulation in animals.
JPS51150940A (en)	1976-12-24	Cashless card and cashless system
ZA873127B (en)	1988-03-30	Method of regulating animal reproduction
JPS5413648A (en)	1979-02-01	Indoor temperature controller system
JPS51143224A (en)	1976-12-09	Car driving device for physically handicapped person
Jamail	1986	The impostor phenomenon and high-achieving men and women issues of sex and self-perceived atypicality.
JPS5235017A (en)	1977-03-17	Train control system
JPS53110440A (en)	1978-09-27	Prevention system for competition between processors
Gallagher	1987	The hubris of philosophy: Alcibiades' praise of Socrates in Plato's Symposium
JPS5319099A (en)	1978-02-21	Commutation ticket issuing apparatus
World Health Organization	1986	Indicators and methods for evaluating the effectiveness of health interventions: an initial review
Ames	1977	The comparison of femoral fracture repair in young calves